SCHEMBL6677558

SCHEMBL6677558

COCc1c(NC(=O)c2ccc(C(=O)O)c(F)c2)cc(C(C)(C)C)cc1C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 11/20 0.47
EPHX2 P34913 2/20 0.47
PPARG P37231 7/20 0.44
SERPINE1 P05121 1/20 0.44
PPARA Q07869 3/20 0.41
CYP2C9 P11712 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
CHEK1 O14757 1/20 0.39
PIM1 P11309 1/20 0.39
MAPK8 P45983 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
PPARD Q03181 1/20 0.39
GPBAR1 Q8TDU6 1/20 0.39
PLK1 P53350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6674764 0.88 POLB (0.45) NR1H4PPARGMEN1TP53GAA
SCHEMBL6673929 0.83 NR1H4 (0.50) NR1H4EPHX2PPARGSERPINE1PPARA
SCHEMBL6674562 0.75 NR1H4 (0.56) NR1H4EPHX2PPARGSERPINE1PPARA
SCHEMBL6674068 0.73 POLB (0.46) NR1H4EPHX2PPARGMEN1TP53
SCHEMBL6673833 0.66 RARA (0.53) NR1H4EPHX2MEN1KMT2A
SCHEMBL6676941 0.65 TRPA1 (0.47) NR1H4EPHX2MEN1TP53GAA
SCHEMBL5693694 0.65 SERPINE1 (0.65) NR1H4PPARGSERPINE1PPARAMEN1
SCHEMBL21297713 0.65 HCAR2 (0.41) NR1H4EPHX2MEN1KMT2A
SCHEMBL2301205 0.65 KDM4E (0.54) NR1H4EPHX2CYP2C9CYP1A2CYP3A4
SCHEMBL6109346 0.65 SERPINE1 (0.77) NR1H4PPARGSERPINE1PPARAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862555-B1 SUBSTITUTED ARYL OR HETEROARYLAMIDES HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN INC (US) 2004-10-20 EP disclosed
US-6610744-B2 Administering to a mammal a retinoid campound which binds specifically or selectively to a RAR alpha retinoid receptors in preference over RAR beta and RAR Gamma retinoid receptors, for therapy and prophylaxisof disease or condition ALLERGAN, INC. 2003-08-26 US disclosed